{"filing":{"accession_number":"0001213900-26-086947","cik":"0001871321","ticker":"DRTSW","company_name":"Alpha Tau Medical Ltd.","form":"6-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"ea0301309-6k_alpha.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1871321/000121390026086947/ea0301309-6k_alpha.htm"},"events":[{"id":26386,"run_id":23977,"accession_number":"0001213900-26-086947","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"Alpha Tau announced its intention to register for dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing. This is a material strategic and operational milestone—a significant capital markets event affecting where and how the company's shares trade—but does not fit the specific event-type taxonomy (not M\u0026A, not a delisting risk, not a dilutive issuance, not a periodic report). The press release explicitly states the company \"has requested to register\" shares and expects them to trade on TASE under symbol DRTS, making this a discrete operational/strategic event rather than a routine administrative disclosure.","company_name":"Alpha Tau Medical Ltd.","ticker":"DRTSW","filing_date":"2026-08-10","form":"6-K","submitted_at":null,"items":[{"id":27483,"accession_number":"0001213900-26-086947","item_number":"EX-99.1","item_title":"ea030130901ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Alpha Tau announced its intention to register for dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing. This is a material strategic and operational milestone—a significant capital markets event affecting where and how the company's shares trade—but does not fit the specific event-type taxonomy (not M\u0026A, not a delisting risk, not a dilutive issuance, not a periodic report). The press release explicitly states the company \"has requested to register\" shares and expects them to trade on TASE under symbol DRTS, making this a discrete operational/strategic event rather than a routine administrative disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-10T12:01:43.356036+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27483,"accession_number":"0001213900-26-086947","item_number":"EX-99.1","item_title":"ea030130901ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Alpha Tau announced its intention to register for dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing. This is a material strategic and operational milestone—a significant capital markets event affecting where and how the company's shares trade—but does not fit the specific event-type taxonomy (not M\u0026A, not a delisting risk, not a dilutive issuance, not a periodic report). The press release explicitly states the company \"has requested to register\" shares and expects them to trade on TASE under symbol DRTS, making this a discrete operational/strategic event rather than a routine administrative disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-10T12:01:43.356036+00:00","company_name":"Alpha Tau Medical Ltd.","ticker":"DRTSW","filing_date":"2026-08-10"}]}